Highlights from SSO25
The SSO 2025 Annual Meeting will be held from March 27-29, 2025, in Tampa, FL, featuring educational sessions, specialized content by disease site, programs for advanced practice providers, residents, and fellows, as well as friendly competitions and expanded networking opportunities.
Many physicians and organizations have shared posts from SSO2025:
“Great turnout of NCI Surgical Oncology Alumni at SSO2025. Celebrated our legacy of translational immunotherapy, Steve Rosenberg and the early pioneers that came thru the surgery branch, (re)connected with alumni/trainees, and laid plans for the future.”
“At SSO2025, Sean Dineen, joined me to discuss the advanced techniques used to treat peritoneal disease, which is a rare manifestation where cancer spreads from its site of origin into the lining of the abdominal cavity.”
“Honored, grateful, and humbled to have our work with underrepresented, rare cancer patients selected for presentation at SSO2025.
Ceaselessly amazed by the new research and innovations, and even more impressed by my co-fellows and residents. ”
“And another fabulous presentation by one of our MD Anderson Cancer Center breast surgical oncology fellows at SSO2025! Dr Ashley Cairns reported data on SLND omission in breast cancer patients with TNBC.”
“Inspiring Presidential Address by the University of Pennsylvania’s Department of Surgery.
Chair Ronald de Matteo on his journey to becoming a physician-scientist on GIST and immunology.
Excited to learn he is a fellow Johns Hopkins University alumni as well as my Memorial Sloan Kettering Cancer Center fellowship PD.”
“Melanoma session kicking off at SSO2025. Honored to be a moderator and thoroughly impressed with the quality of these amazing talks. Congrats to all the speakers.”
“What a gratifying experience to be part of the Society of Surgical Oncology’s Surgical Oncology Pathways to Health Engagement, Representation, and Education Committee (SPHERE).
A big shoutout to the inaugural class of the Foster the Future program! Meet five exceptional young surgeons-in-training from diverse backgrounds, all driven to enhance cancer outcomes for everyone. With Foster the Future, they’ll benefit from mentorship, sponsorship, and guidance provided by seasoned SSO members.
Reflecting on my own path as a young surgical oncologist, mentorship has played a pivotal role and continues to shape my journey. Proud to be part of an organization committed to advancing equitable healthcare.”
“80% of all cancer patients will require a surgical procedure, yet in Africa, 9/10 have no access to safe, timely surgery.
We (AORTIC- Africa) will be participating in the SSO2025 meeting.
As part of our ongoing MOU with the Society of Surgical Oncology (SSO), we are looking for ways to expand surgical capacity in Africa. The SSO supports the International Career Development Exchange Program.
This initiative allows surgical oncologists involved in cancer surgery to attend the annual SSO meeting and spend 1-2 weeks at a center of their choice—building connections, gaining experience, and sharing knowledge on best practices.
This partnership is crucial because cancer surgery lags behind other treatment modalities, despite covering the full spectrum of care, from diagnosis and prevention to treatment and palliation. It’s a critical piece that needs more focus.
We are proud of this year’s recipient, a practicing surgical oncologist from Angola, Dr. iryna jacinto based at Irene Neto Hospital and one of our AORTIC- Africa, Africa Cancer Leaders initiative (ACLI). She is committed to making a difference in cancer care in her region.
Sending a spotlight her way!”
“Fabulous presentation by Kelley Chan and Chandler S Cortina on breast cancer in transgender patients – tend to be younger but still have worse overall survival? So much to learn!”
“Another successful meeting of the Transatlantic Australasian RetroPeritoneal Sarcoma Working Group on the occasion of the annual meeting of the Society of Surgical Oncology.
John E. Mullinax is a wonderful host. An overview of the achievements of the past years to brainstorm about the current and future endeavors.
A thorough discussion about the prospective registry RESAR: overall, over 3000 patients included; actions to improve the quality of the collected data even further; timing of data submission; the importance of the consecutiveness of the patients. Surveillance is the first randomized registry-based study.
A framework agreement to share omics data. New studies on the Horizon, such as ReLapse. Discussion about the status of STRASS2 and STREXIT2. Brainstorm about the next RESAR studies and STRASS3.
Lots of interactions and enthusiasm as always. It’s fantastic to see how this global collaboration moves forward and becomes stronger and stronger over the years!”
“As SSO2025 concludes, we’re proud to celebrate the impactful work shared by Moffitt’s surgical experts and the opportunity to exchange ideas and trial data. We loved welcoming surgeons from around the world and look forward to Society of Surgical Oncology returning to Tampa in 2028! ”
“Kelly Olino highlights the importance of balancing risk v. reward in patient selection for TIL therapy based on experience with melanoma and future directions to improve the treatment platform SSO2025. ”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023